Log in to save to my catalogue

18F‐AV‐1451 and CSF T‐tau and P‐tau as biomarkers in Alzheimer's disease

18F‐AV‐1451 and CSF T‐tau and P‐tau as biomarkers in Alzheimer's disease

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_0d11d7a17e0a419bb17eb9b405b94773

18F‐AV‐1451 and CSF T‐tau and P‐tau as biomarkers in Alzheimer's disease

About this item

Full title

18F‐AV‐1451 and CSF T‐tau and P‐tau as biomarkers in Alzheimer's disease

Publisher

London: Nature Publishing Group UK

Journal title

EMBO molecular medicine, 2017-09, Vol.9 (9), p.1212-1223

Language

English

Formats

Publication information

Publisher

London: Nature Publishing Group UK

More information

Scope and Contents

Contents

To elucidate the relationship between cerebrospinal fluid (CSF) total‐tau (T‐tau) and phosphorylated tau (P‐tau) with the tau PET ligand
18
F‐AV‐1451 in Alzheimer's disease (AD), we examined 30 cognitively healthy elderly (15 with preclinical AD), 14 prodromal AD, and 39 AD dementia patients. CSF T‐tau and P‐tau were highly correlated (
R<...

Alternative Titles

Full title

18F‐AV‐1451 and CSF T‐tau and P‐tau as biomarkers in Alzheimer's disease

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_0d11d7a17e0a419bb17eb9b405b94773

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_0d11d7a17e0a419bb17eb9b405b94773

Other Identifiers

ISSN

1757-4676

E-ISSN

1757-4684

DOI

10.15252/emmm.201707809

How to access this item